Harpoon Therapeutics Inc (HARP) has released an update to notify the public and investors about corporate charter and bylaws modifications.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Harpoon Therapeutics, Inc. amended its Certificate of Designation for its 8.000% Series A Redeemable Preferred Stock to incorporate changes from a one-for-ten reverse stock split of its common stock that took place on September 1, 2023. This amendment was filed with the Secretary of State of Delaware on January 26, 2024.
For further insights into HARP corporate activity, check out TipRanks’ Insiders Trading Activity page.